The Care Quality Commission, during its visit to Lincoln County Hospital CQC in November identified major concerns with three essential standards of quality and safety: the care and welfare of people; supporting staff; and assessing and monitoring the quality of service provision.
Crohn’s and colitis – care improving but services fall short in key areas
The third round of the UK Inflammatory Bowel Disease Audit, carried out in 2010, shows that care for patients with ulcerative colitis and Crohn's disease has improved across a wide range of measures since the previous two rounds. However, there is still room for improvement.
Care improving for children with crohn’s and colitis, but could be better
The second round of the UK Paediatric Inflammatory Bowel Disease Audit shows that while children with ulcerative colitis (UC) and Crohn’s disease (CD) has improved greatly since the previous audit in 2008, there is room for improvement:
1. All children with IBD need to be tested for infections during a disease flare, especially for Clostridium Difficile (CDiff)
2. More children with IBD should see a specialist paediatric IBD nurse during their stay in hospital
3. More children should see a dietician to optimise nutrition
Quarter of physicians say continuity of care is poor in their hospital
A new survey from the Royal College of Physicians (RCP) found that over a quarter (28%) of consultant physicians surveyed rate their hospital’s ability to deliver continuity of care as poor or very poor.
New quarterly figures showing the quality of stroke care in hospitals in England and Northern Ireland now available.
The latest results for the Stroke Improvement National Audit Programme (SINAP) below are for patients admitted between October 2011 and December 2011 and include ‘key indicators’ of care provided. Individual hospital results, compared with national level results, are now available, including details of non-participating hospitals.
Greater options for patients with type 2 diabetes
NICE has approved the use of exenatide in triple therapy regimens for patients with type 2 diabetes. Patients should be offered the drug if they are struggling to control their blood glucose levels or if they remain inadequate.
Green light for earlier use of rheumatoid arthritis drug
Patients with rheumatoid arthritis can now be offered tocilizumab alongside other treatment options at an earlier stage. The drug is recommended, in combination with methotrexate, for treating rheumatoid arthritis if treatment with disease-modifying anti-rheumatic drugs (DMARDS) has failed.
Improving access to NICE-approved drugs
NICE is to produce a best practice guide to help trusts develop local formularies, as part of a move to ensure that all patients in England have access to clinically and cost-effective drugs.
Subscribe to:
Posts (Atom)
This bulletin is brought to you by Library and Knowledge Services. It aims to keep you up-to-date with clinical governance issues. At the beginning of each month, a librarian will update the bulletin with relevant information published in the preceding month. If there are areas you think we also need to cover, please let us know.
.jpg)